Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas

Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, Ciudad de México
Select an option

Our team

Medical staff
Jorge Rojas-Serrano
Mayra Edith Mejía Ávila
Andrea Estrada Garrido
Brenda Flores

Open studies

Chronic bronchitis
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure - National Institute of Respiratory Diseases, MexicoSee more
Chronic obstructive pulmonary disease
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure - National Institute of Respiratory Diseases, MexicoSee more
Covid-19
Outpatient Treatment With Anti-Coronavirus Immunoglobulin - OTAC - International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)See more
Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes - TREASURE-CKD - Eli Lilly and CompanySee more
Obesity
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes - TREASURE-CKD - Eli Lilly and CompanySee more
Renal disease
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes - TREASURE-CKD - Eli Lilly and CompanySee more
Tobacco Use
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects - National Institute of Respiratory Diseases, MexicoSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy